2:30 – 3:30 pm Friday, September 4

How to Return Research Results to Patients and Families? The Children’s Oncology Group Experience (C232)

coglogoIn North America, the majority of children with cancer will enroll in a clinical trial at some point during their treatment. Clinical research is rooted in the premise that the quantity and quality of human lives will be improved by carefully conducted clinical and basic research.

Read more...
Speaker:
Kimberly Pyke-Grimm, PhD RN CNS CPHON®
CNE Hours
1
12:15 – 1:15 pm Friday, September 4

High Risk Neuroblastoma in the new decade: Incorporating targeted therapies to maximize impact in current Children’s Oncology Group trials (C226)

coglogoWhile the overall cure rate for childhood cancer is approaching 80%, the prognosis for long-term survival for children with high risk neuroblastoma lags considerably behind, at 50%–60%. Upfront standard treatment for high-risk neuroblastoma protocols within the Children’s Oncology Group (COG) has historically utilized all available modalities of cancer treatment including chemotherapy, surgery, myeloablative chemotherapy with stem cell rescue, radiation therapy, differentiating agents, and most recently biologic therapy with anti-GD2 antibody (dinutuximab) used post consolidation in ANBL0032.

Read more...
Speaker:

Wendy Fitzgerald, MSN APRN PPCNP-BC

Denise Mills, MN RN(EC) NP CPHON®

CNE Hours
1
12:15 – 1:15 pm Thursday, September 3

Caring for Pediatric Patients with Malignant Bone Tumors: The Advanced Practice Nurse’s Perspective (213)

Children, adolescents, and young adults with malignant bone tumors require expert and specialized care beginning at diagnosis and continuing throughout therapy and beyond. Each patient’s treatment plan is likely to include systemic chemotherapy plus radiation and/or surgery to achieve local tumor control.

Read more...
Speaker:
Kristen Dalton, MSN RN CPNP-AC CPHON®
Elizabeth Cummings, MSN RN CPNP-AC CPHON®
Amy Rapino, MSN CRNP
CNE Hours
1
3:30 – 4:30 pm Wednesday, September 2

Same Chorus, Different Tune: Interactive Teaching Techniques for Chemotherapy-Biotherapy Instructors (208)

The Chemotherapy/Biotherapy Provider Program Committee is committed to the ongoing support of more than 550-course instructors as they continue to adapt to the content and lectures of the 4th edition curriculum.

Read more...
Speaker:
Ruth Anne Herring, MSN RN CPNP-AC/PC CPHON®
Michael Hans, MS BSN RN NPD-BC CPON®
Kristin Belderson, DNP RN NPD-BC CPON®
Joy Hesselgrave, MSN RN CHPPN CPON®
Colleen Nixon, MSN RN CPHON®
Joan O'Hanlon Curry, MS RN CPNP CPON®
CNE Hours
1
3:30 – 4:30 pm Wednesday, September 2

Solid and CNS Tumors at Relapse: Creativity and Challenges for the APN (206)

Advanced practice providers are consistently challenged to help provide and deliver new and innovative therapies at the time of relapse. Solid and central nervous system tumors rarely have well-proven, successful treatments at the time of relapse or progression on therapy.

Read more...
Speaker:
Molly Hemenway, DNP MS AC/PC-CPNP
Suzanne Smolik, MSN RN CPNP CPON®
Phyli Forsberg, MSN RN PNP
CNE Hours
1
11:15 – 11:45 am Wednesday, September 2

Reducing Preventable Harm: Quality Improvement Strategies to Reduce Chemotherapy/Biotherapy Medication Administration Errors (203-2)

Medication administration errors (MAE) are among the most common adverse events causing patients during treatment. These events are nearly always preventable. Although any MAE is problematic, patients treated with chemotherapy and biotherapy agents are at risk for significant harm due to the inherent hazards of the medications and the complexity of treatment protocols.

Read more...
Speaker:
Mindy Bibart, MSN RN  NE-BC CSSBB CPHON®
CNE Hours
0.5
10:45 – 11:45 am Wednesday, September 2

What Every Nurse Needs to Know About Drug Shortages (202)

Shortages of essential drugs can have a significant impact on the health of children worldwide. In pediatric oncology, drug shortages are particularly impactful. Childhood cancer treatment relies heavily on the use of sterile injectable generic agents, which make up the majority of scarce medications.

Read more...
Speaker:
Dyane Bunnell, MSN APRN AOCNS CPON®
Susie Burke, MA BSN CPNP CPHON®
Michele Casey, MN NP RN
Caity Hubrig, BSN RN CPN CPHON®
CNE Hours
1
Subscribe to this RSS feed